LIVE
New today 401
Updated 1,094
New executives 3,336
Reported capital $ 1,426,000

PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA)

CORPORATION (JOINT-STOCK COMPANY) ACTIVE No ranking1,007,204 total
RUC: 155705433-2-2021
Total views
20
Avg / month
2
Year peak
6
Current month -33.3 % vs Sep
4

Company information

Folio
155705433 Mercantil
Registration date
Validity
PERPETUAL
Status
ACTIVE
Last update
06/08/2023 (hace 2 años)

Highlights PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA)

Currency
NO-PAR VALUE SHARES
Share capital
-
RUC
155705433-2-2021

Executives PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA) (7)

Name
Role
Links
View
  • Name GALINDO, ARIAS Y LÓPEZ Resident Agent 684
    Role: Resident Agent
    Links: 684
  • Name GINES ALBERTO SANCHEZ URRUTIA Director / President 10
    Role: Director / President
    Links: 10
  • Name JORGE ANTONIO SANCHEZ URRUTIA Director / Vice President 9
    Role: Director / Vice President
    Links: 9
  • Name JORGE ANTONIO SANCHEZ URRUTIA Treasurer 9
    Role: Treasurer
    Links: 9
  • Name LUCIA DEL CARMEN SANCHEZ GONZALEZ Director / Secretary 2
    Role: Director / Secretary
    Links: 2
  • Name GGH & CO., S.A. Subscriber 889
    Role: Subscriber
    Links: 889
  • Name LEC & CIA., S.A. Subscriber 720
    Role: Subscriber
    Links: 720
  • Name EL REPRESENTANTE LEGAL SERÁ EL PRESIDENTE, EN SU AUSENCIA, EN SU ORDEN, EL VICEPRESIDENTE, O EL TESORERO O EL SECRETARIO. REPRESENTATIVE -
    Role: REPRESENTATIVE
    Links: -
*Links: number of companies where the executive appears with a role or relation.

Documents PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA) (2)

Act
Date
View
  • Act Electronic Entry Nº 2 (CORRECTION) Entry 151140/2021 (0) 04/05/2021
    Date: 04/05/2021
  • Act Electronic Entry Nº 1 (Opening of Electronic Folio) Entry 144394/2021 (0) 28/04/2021
    Date: 28/04/2021

Entries / Precedence PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA) (2)

Procedure / Document type
Year
View
  • Procedure / Doc. Correction Due to Registry-Attributed Causes 2021
    Year: 2021
  • Procedure / Doc. Incorporation of Company Capital, Single Fee, Qualification Rights 2021
    Year: 2021
About PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA): Summary of PROMED CANCER THERAPIES DE CENTROAMERICA, S.A. (PCT DE CA): entity CORPORATION (JOINT-STOCK COMPANY), status VIGENTE. Address in District Panamá, Province Panamá. Registered since 28/04/2021. Estimated traffic: 20 total visits (peak 6). Position: no ranking available. See representatives, branches, documents and filings.